Danaparoid and pulmonary embolism Patient Reports February 12, 2012



Danaparoid Side Effects Report #5275224-4
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Mar 08, 2007. Female patient, 78 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: deep vein thrombosis What is  deep vein thrombosis, disease recurrence, heparin-induced thrombocytopenia, pulmonary embolism What is  pulmonary embolism. Danaparoid dosage: unknown. During the same period patient was treated with TRIMEBUTINE MALEATE, ACETAMINOPHEN, MORPHINE SULPHATE, MACROGOL, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5097841-7
Danaparoid side effect was reported by a Consumer or non-health professional from CANADA on Aug 29, 2006. Female patient, 78 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, pulmonary embolism What is  pulmonary embolism, respiratory gas exchange disorder. Danaparoid dosage: unknown. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5119938-5
Danaparoid side effect was reported by a Consumer or non-health professional from CANADA on Aug 29, 2006. Female patient, 78 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, heparin-induced thrombocytopenia, pulmonary embolism What is  pulmonary embolism, respiratory gas exchange disorder. Danaparoid dosage: unknown. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #4985064-9
Danaparoid side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 09, 2006. Female patient, 56 years of age, was diagnosed with heparin-induced thrombocytopenia, thrombosis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease recurrence, lacunar infarction, pulmonary embolism What is  pulmonary embolism, thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.


Danaparoid Side Effects Report #5139616-6
Danaparoid side effect was reported by a Consumer or non-health professional from AUSTRALIA on Oct 17, 2006. Female patient was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: pulmonary embolism What is  pulmonary embolism. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.

Danaparoid Side Effects Report #4877895-0
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 04, 2006. Male patient, 86 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cross sensitivity reaction, pulmonary embolism What is  pulmonary embolism, thrombocytopenia, venous thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with ENOXAPARIN, HEPARIN CALCIJM. Patient recovered.

Danaparoid Side Effects Report #5050408-9
Danaparoid side effect was reported by a Consumer or non-health professional from CANADA on June 26, 2006. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: pulmonary embolism What is  pulmonary embolism, respiratory gas exchange disorder, thrombocytopenia. Danaparoid dosage: unknown. Patient recovered.

Danaparoid Side Effects Report #4975620-6
Danaparoid side effect was reported by a Health Professional from GERMANY on Apr 03, 2006. Male patient, 62 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease recurrence, platelet count decreased, pulmonary embolism What is  pulmonary embolism, thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISONE, AMPHOTERICIN B, NITRENDIPINE. Patient died.

Danaparoid Side Effects Report #4907161-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 30, 2006. Female patient, 52 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, pancreatitis, pulmonary embolism What is  pulmonary embolism. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, NADROPARIN CALCIUM. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Danaparoid